FDA6DC422EE4013F790BF68C778B35146686FCBAD4F8C9227707D93553F0BC7E13C4D502159C6A1678BCA3F50289DBE5C8E136B22C91750CF3E02373AFAE73376A23FF860B07585E8C81F02D74CB881D0308AFEEC29095D49A6FB3767391DCECDD9920B32F41DBF3D4143D5B969670D19DBAF310D6BE8835F3032A5452B8BBA155BFC82DC0B9F96FC721174E5425C5D994DB0AF36A857B3B8C5692A2E1784F8F40E88BDA635E38F2F4022FD566FDE9D71AB5A5E4067D0C2BC0E6B15D05DEF492568C04437C007ACDBCAA2FB0F45316081A7436A657E8265B7A765CB3E624113F0020C35D52EB495FE131681373B35CBF280B76823F30EDCE6D6FE6FE8CF3928C721F14FF336330F1A908C5A039EBE70039C17908BC6FB5C8BC10252BCD1EB20FB1A7B934CD279780C6AF0A5F622630F347CD558BFA21A06880ED52791DEDA86CA7DD1639AEB8BC59A75CC2F76B4DAB69D90F0EBF23A3D1AEE9874BC465BF80EC9CFE902EF3672A286220736F1F9189E774029FF86B316A8FDA225F0ECC502EF5274A15F48B97958E9D81EBECDF3C45501709CC85FD8E15A9E1133F2D6231194961F13A887289C385D5F0719BB74B728002635D5E6281DA025ED182A92B24E8B0F84FF07F770061A155D31165F74C7A9D30CD08DD9115E9E26BD7938F5E288A815A90135C7CAE6D0A227C498445FC1D356839B3425C8E3F894C47C29D9D63391E